Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

RGEN

Repligen Corp

Feb 13 • 01:06PM ET

136.22

+3.59 2.71 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BIO TMO DHR WAT ILMN BRKR TECH MTD QGEN A

| Held by: VTI IJH VB VBK VXF FBT MDY IBB SPMD VHT

Index	-	P/E	5300.39	EPS (ttm)	0.03	Insider Own	5.46%	Shs Outstand	56.28M	Perf Week	-4.19%
Market Cap	7.67B	Forward P/E	65.58	EPS next Y	2.08	Insider Trans	-2.65%	Shs Float	53.22M	Perf Month	-15.93%
Enterprise Value	7.61B	PEG	3.47	EPS next Q	0.44	Inst Own	111.84%	Short Float	7.62%	Perf Quarter	-13.79%
Income	1.74M	P/S	10.83	EPS this Y	5.32%	Inst Trans	5.94%	Short Ratio	5.89	Perf Half Y	7.56%
Sales	707.89M	P/B	3.68	EPS next Y	24.81%	ROA	0.06%	Short Interest	4.05M	Perf YTD	-16.87%
Book/sh	37.01	P/C	10.24	EPS next 5Y	18.91%	ROE	0.08%	52W High	175.77 -22.50%	Perf Year	-6.81%
Cash/sh	13.30	P/FCF	72.01	EPS past 3/5Y	- -	ROIC	0.06%	52W Low	102.96 32.30%	Perf 3Y	-27.60%
Dividend Est.	-	EV/EBITDA	44.51	Sales past 3/5Y	-1.83% 18.61%	Gross Margin	46.80%	Volatility	5.08% 4.87%	Perf 5Y	-39.79%
Dividend TTM	-	EV/Sales	10.75	EPS Y/Y TTM	120.01%	Oper. Margin	6.60%	ATR (14)	7.24	Perf 10Y	493.03%
Dividend Ex-Date	-	Quick Ratio	7.14	Sales Y/Y TTM	11.74%	Profit Margin	0.25%	RSI (14)	30.85	Recom	1.52
Dividend Gr. 3/5Y	- -	Current Ratio	8.36	EPS Q/Q	2354.70%	SMA20	-10.46%	Beta	1.15	Target Price	191.67
Payout	-	Debt/Eq	0.33	Sales Q/Q	21.91%	SMA50	-14.52%	Rel Volume	0.99	Prev Close	132.63
Employees	1778	LT Debt/Eq	0.32	Earnings	Feb 24 BMO	SMA200	-2.06%	Avg Volume	688.59K	Price	136.22
IPO	Apr 29, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.11% 3.64%	Trades		Volume	391,313	Change	2.71%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-25	Initiated	HSBC Securities	Buy	$150
Sep-22-25	Upgrade	Evercore ISI	In-line → Outperform	$155
Jul-22-25	Resumed	Stephens	Overweight	$160
Jun-24-25	Initiated	Barclays	Overweight	$150
Apr-29-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$160
Mar-18-25	Initiated	Evercore ISI	In-line	$155
Feb-10-25	Initiated	TD Cowen	Buy	$200
Dec-17-24	Initiated	Canaccord Genuity	Hold	$165
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Aug-28-24	Initiated	Wells Fargo	Overweight	$180
Jun-26-24	Upgrade	Deutsche Bank	Hold → Buy	$180 → $155
Jun-18-24	Initiated	Guggenheim	Neutral
Dec-04-23	Downgrade	The Benchmark Company	Buy → Hold
Jul-20-23	Initiated	Wells Fargo	Overweight	$185
Jul-05-23	Resumed	JP Morgan	Overweight	$220
Mar-28-23	Initiated	The Benchmark Company	Buy	$230
Dec-14-22	Initiated	Deutsche Bank	Hold	$180
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$190
Jul-20-22	Initiated	UBS	Buy	$213
Oct-14-21	Initiated	Exane BNP Paribas	Outperform	$330

Show Previous Ratings

Feb-10-26 07:30AM	Repligen to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-06-26 08:16AM	What Makes Repligen Corporation (RGEN) an Investment Choice? (Insider Monkey)
Feb-04-26 08:04PM	Analyst Report: Repligen Corporation (Morningstar Research)
Jan-26-26 11:01PM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Jan-22-26 09:52PM	UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds (Insider Monkey)
02:15PM	Loading…
Jan-14-26 02:15PM	Why Repligen (RGEN) Shares Are Sliding Today (StockStory)
Jan-06-26 07:30AM	Repligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair (GlobeNewswire)
Dec-18-25 07:30AM	Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference (GlobeNewswire)
Dec-17-25 08:35AM	Here's Why Sands Capital Global Growth Fund Decided to Sell Repligen Corporation (RGEN) (Insider Monkey)
Dec-16-25 07:30AM	Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows (GlobeNewswire)
Dec-07-25 11:35PM	1 Volatile Stock to Target This Week and 2 We Turn Down (StockStory)
Dec-03-25 11:30AM	Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report? (Zacks)
Nov-26-25 07:30AM	Repligen Corporation to Present at Evercore Healthcare Conference (GlobeNewswire)
Nov-21-25 07:09PM	Analyst Report: Repligen Corporation (Morningstar Research) +5.28%
06:36PM	Why Repligen (RGEN) Stock Is Trading Up Today (StockStory)
10:31PM	Loading…
Nov-06-25 10:31PM	Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Nov-04-25 07:30AM	Repligen Corporation to Present at Upcoming November Conferences (GlobeNewswire)
12:32AM	5 Revealing Analyst Questions From Repligen's Q3 Earnings Call (StockStory)
Oct-30-25 07:45PM	Analyst Report: Repligen Corporation (Morningstar Research)
Oct-29-25 01:13PM	Analyst Report: Repligen Corporation (Morningstar Research)
11:18AM	RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down (Zacks)
09:40AM	RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset (StockStory)
Oct-28-25 02:35PM	Why Repligen (RGEN) Shares Are Trading Lower Today (StockStory) -5.92%
08:45AM	Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
08:01AM	Repligen's (NASDAQ:RGEN) Q3 Sales Beat Estimates (StockStory)
07:40AM	Repligen: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Oct-27-25 09:22AM	Earnings To Watch: Repligen Corp (RGEN) Reports Q3 2025 Result (GuruFocus.com)
Oct-26-25 11:13PM	Repligen Earnings: What To Look For From RGEN (StockStory)
Oct-23-25 07:15PM	Analyst Report: Repligen Corporation (Morningstar Research)
10:00AM	Loading…
10:00AM	Apellis Pharmaceuticals, Inc. (APLS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-21-25 11:40AM	ALKS vs. RGEN: Which Stock Is the Better Value Option? (Zacks)
10:00AM	Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline (Zacks)
Oct-15-25 07:30AM	Repligen to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-09-25 07:46AM	Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? (Insider Monkey)
Oct-01-25 12:20PM	Why Is Repligen (RGEN) Stock Soaring Today (StockStory) +9.08%
Sep-30-25 04:05PM	Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know (StockStory) +7.72%
Sep-24-25 12:04AM	3 Reasons to Sell RGEN and 1 Stock to Buy Instead (StockStory)
Sep-22-25 11:31PM	Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN) (StockStory)
Sep-16-25 02:51PM	Repligen (RGEN) Stock Is Up, What You Need To Know (StockStory) +5.28%
Sep-12-25 02:26PM	Why Repligen (RGEN) Stock Is Down Today (StockStory)
Aug-22-25 03:40PM	Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know (StockStory)
07:30AM	Repligen Corporation to Present at Upcoming September Conferences (GlobeNewswire)
Aug-20-25 08:42AM	Do Options Traders Know Something About Repligen Stock We Don't? (Zacks)
Aug-12-25 12:53AM	RGEN Q2 Deep Dive: Chromatography and Filtration Drive Growth, Guidance Lifted Amid New Modalities Uncertainty (StockStory) +8.51%
12:35AM	5 Must-Read Analyst Questions From Repligen's Q2 Earnings Call (StockStory)
Aug-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-31-25 07:30AM	Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization (GlobeNewswire)
Jul-29-25 11:52PM	Analyst Report: Repligen Corporation (Morningstar Research)
02:26PM	Why Repligen (RGEN) Stock Is Up Today (StockStory)
08:45AM	Repligen (RGEN) Lags Q2 Earnings Estimates (Zacks)
08:09AM	Repligen's (NASDAQ:RGEN) Q2 Sales Top Estimates, Full-Year Sales Guidance is Optimistic (StockStory)
07:41AM	Repligen: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance (GlobeNewswire)
Jul-28-25 09:22AM	Repligen Corp (RGEN) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-27-25 11:06PM	Repligen (RGEN) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-22-25 09:40AM	Netflix downgraded, Intel initiated: Wall Street's top analyst calls (The Fly)
Jul-21-25 09:45AM	Here's Why Repligen (RGEN) is a Strong Growth Stock (Zacks)
Jul-18-25 03:11PM	Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know (StockStory) -6.28%
12:03AM	3 Reasons RGEN is Risky and 1 Stock to Buy Instead (StockStory)
Jul-17-25 07:30AM	Repligen to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jun-24-25 02:18PM	5 Insightful Analyst Questions From Repligen's Q1 Earnings Call (StockStory)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-04-25 11:36PM	Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-03-25 11:32PM	Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers (StockStory)
Jun-02-25 01:36PM	Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? (Zacks)
May-29-25 11:30AM	Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? (Zacks)
May-27-25 07:30AM	Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report (GlobeNewswire)
May-22-25 07:30AM	Repligen Corporation to Present at William Blair Growth Conference (GlobeNewswire)
May-09-25 12:36AM	1 High-Flying Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
May-07-25 07:30AM	Repligen Corporation to Present at Upcoming May Investor Conferences (GlobeNewswire)
May-02-25 11:40AM	QGEN or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
08:18AM	Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare (Insider Monkey)
May-01-25 12:11PM	Jim Cramer on Repligen Corporation (RGEN): 'I'm Not Quite Ready to Stick My Neck Out on This One' (Insider Monkey)
Apr-30-25 04:19PM	RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty (StockStory)
10:55AM	Analyst Report: Repligen Corporation (Morningstar Research)
09:07AM	Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y (Zacks)
03:09AM	Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
12:58PM	Repligen Corporation (RGEN) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:45AM	Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:05AM	Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
07:45AM	Repligen: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Repligen Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 07:08PM	What To Expect From Repligen Corp (RGEN) Q1 2025 Earnings (GuruFocus.com)
03:08AM	Repligen (RGEN) Q1 Earnings: What To Expect (StockStory)
Apr-25-25 09:16AM	3 Healthcare Stocks That Concern Us (StockStory)
Apr-23-25 12:10PM	Will Repligen (RGEN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:01AM	Earnings Preview: Guardant Health (GH) Q1 Earnings Expected to Decline (Zacks)
Apr-22-25 10:01AM	Repligen (RGEN) Reports Next Week: Wall Street Expects Earnings Growth (Zacks) +5.54%
Apr-16-25 11:40AM	GMAB or RGEN: Which Is the Better Value Stock Right Now? (Zacks)
Apr-15-25 07:30AM	Repligen to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-10-25 05:03AM	Repligen (RGEN): Buy, Sell, or Hold Post Q4 Earnings? (StockStory) -6.99%
Apr-08-25 07:30AM	Repligen Appoints Jacob Johnson As Vice President Investor Relations (GlobeNewswire) -6.22%
04:11AM	Repligen (RGEN) Moves 3.7% Higher: Will This Strength Last? (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-25-25 12:46PM	Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management? (Insider Monkey)
Mar-20-25 07:52AM	Repligen: Ongoing Bioprocessing Market Recovery (SeekingAlpha)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:01AM	Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks (StockStory)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAWES KAREN A	Director	Dec 17 '25	Sale	161.00	275	44,275	91,821	Dec 18 04:30 PM
MUIR GLENN P	Director	Dec 16 '25	Option Exercise	26.12	3,366	87,920	36,622	Dec 17 04:30 PM
DAWES KAREN A	Director	Dec 17 '25	Proposed Sale	161.00	275	44,275		Dec 17 04:28 PM
Loeillot Olivier	Chief Executive Officer	Nov 25 '25	Sale	170.00	7,041	1,196,970	35,898	Nov 26 04:30 PM
Loeillot Olivier	Officer	Nov 25 '25	Proposed Sale	170.00	7,041	1,196,970		Nov 25 12:06 PM
Bylund James	Chief Operating Officer	Nov 18 '25	Sale	151.21	2,191	331,301	21,520	Nov 19 04:30 PM
Bylund James	Officer	Nov 18 '25	Proposed Sale	151.21	2,191	331,304		Nov 18 04:10 PM
Hunt Anthony	Director	Nov 13 '25	Option Exercise	33.87	2,952	99,984	83,695	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Sale	154.61	20,000	3,092,278	80,743	Nov 14 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Option Exercise	33.87	25,000	846,750	125,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 12 '25	Sale	156.88	25,000	3,921,940	100,743	Nov 13 04:30 PM
Hunt Anthony	Director	Nov 13 '25	Proposed Sale	154.62	20,000	3,092,327		Nov 13 04:11 PM
Hunt Anthony	Director	Nov 12 '25	Proposed Sale	156.88	25,000	3,921,981		Nov 12 04:37 PM
Hunt Anthony	Director	Sep 10 '25	Option Exercise	33.87	20,000	677,400	129,854	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Sale	120.52	29,111	3,508,389	100,743	Sep 11 02:55 PM
Hunt Anthony	Director	Sep 10 '25	Proposed Sale	120.52	29,111	3,508,378		Sep 10 04:22 PM
Madaus Martin D	Director	Aug 08 '25	Buy	112.13	1,800	201,830	1,800	Aug 12 12:47 PM
Hunt Anthony	Director	May 15 '25	Sale	123.71	26,447	3,271,688	109,854	May 16 03:02 PM
Hunt Anthony	Director	May 15 '25	Proposed Sale	128.34	26,447	3,394,208		May 15 10:25 AM
Hunt Anthony	Director	Mar 17 '25	Option Exercise	54.73	26,756	1,464,267	163,057	Mar 19 04:21 PM
Hunt Anthony	Director	Mar 17 '25	Sale	152.51	26,756	4,080,663	136,301	Mar 19 04:21 PM
Pax Margaret	Director	Mar 17 '25	Buy	150.69	250	37,672	1,043	Mar 18 03:58 PM
Hunt Anthony	Director	Mar 17 '25	Proposed Sale	150.42	26,756	4,024,638		Mar 17 10:04 AM

Open in Screener

TWST

Twist Bioscience Corp

Feb 13 • 01:06PM ET

48.74

+1.08 2.27 %

Healthcare • Diagnostics & Research • USA • NASD

TWST Twist Bioscience Corp daily Stock Chart

Peers: ILMN PACB CRSP EDIT NTLA BEAM SGMO AMGN REGN BIIB

| Held by: ARKK ARKG XBI IWM VTI VB IWO VBK VXF IBB

Index	RUT	P/E	-	EPS (ttm)	-1.27	Insider Own	4.51%	Shs Outstand	61.27M	Perf Week	-1.02%
Market Cap	2.99B	Forward P/E	-	EPS next Y	-1.20	Insider Trans	-8.27%	Shs Float	58.55M	Perf Month	21.76%
Enterprise Value	2.89B	PEG	-	EPS next Q	-0.48	Inst Own	131.14%	Short Float	20.78%	Perf Quarter	52.93%
Income	-76.58M	P/S	7.63	EPS this Y	-38.63%	Inst Trans	2.36%	Short Ratio	8.08	Perf Half Y	69.00%
Sales	391.56M	P/B	6.55	EPS next Y	33.67%	ROA	-12.29%	Short Interest	12.17M	Perf YTD	53.66%
Book/sh	7.44	P/C	15.10	EPS next 5Y	23.15%	ROE	-16.79%	52W High	51.00 -4.43%	Perf Year	3.99%
Cash/sh	3.23	P/FCF	-	EPS past 3/5Y	31.51% 18.31%	ROIC	-14.13%	52W Low	23.30 109.18%	Perf 3Y	103.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.76% 33.11%	Gross Margin	51.62%	Volatility	5.76% 6.05%	Perf 5Y	-70.97%
Dividend TTM	-	EV/Sales	7.38	EPS Y/Y TTM	62.54%	Oper. Margin	-34.35%	ATR (14)	2.67	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.37	Sales Y/Y TTM	18.59%	Profit Margin	-19.56%	RSI (14)	64.55	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	3.78	EPS Q/Q	6.46%	SMA20	7.75%	Beta	2.22	Target Price	52.22
Payout	-	Debt/Eq	0.21	Sales Q/Q	16.89%	SMA50	26.84%	Rel Volume	0.62	Prev Close	47.66
Employees	979	LT Debt/Eq	0.19	Earnings	Feb 02 BMO	SMA200	47.93%	Avg Volume	1.51M	Price	48.74
IPO	Oct 31, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-17.92% 1.78%	Trades		Volume	538,509	Change	2.27%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-04-25	Initiated	Stephens	Overweight	$41
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Jun-04-24	Initiated	Guggenheim	Buy	$53
Jan-17-24	Upgrade	Goldman	Neutral → Buy	$25 → $45
Sep-27-23	Initiated	Berenberg	Buy	$27
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform	$28 → $36
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral	$110
Apr-12-21	Initiated	Piper Sandler	Overweight	$150
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight	$100
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform	$90
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral	$27

Show Previous Ratings

Feb-10-26 08:00AM	Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes (Business Wire)
Feb-09-26 12:06PM	Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification (MarketBeat)
Feb-03-26 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-02-26 10:02PM	Twist Bioscience Corporation (TWST): A Bull Case Theory (Insider Monkey) +13.98%
02:27PM	Why Is Twist Bioscience Stock Soaring Monday? (Benzinga)
02:00PM	Loading…
02:00PM	Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:52PM	Twist Bioscience Q1 Earnings Call Highlights (MarketBeat)
08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:21AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results (Business Wire)
Jan-27-26 10:00AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-26-26 10:00AM	Will Twist Bioscience (TWST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jan-12-26 08:00AM	Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue (Business Wire) +7.70%
Dec-31-25 06:26AM	Cathie Wood Doubles Down on Biotech as 2025 Ends, Offloads Rocket Lab (GuruFocus.com)
Dec-30-25 11:48PM	Barclays Keeps Its Overweight Rating On Twist Bioscience Corporation (TWST) (Insider Monkey)
12:51PM	Loading…
Dec-29-25 12:51PM	TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock (GuruFocus.com)
Dec-22-25 10:20PM	New Product Launch Strengthens Bull Case for Twist?Bioscience (?TWST) (Insider Monkey) +7.84%
Dec-18-25 08:00AM	Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference (Business Wire)
Dec-12-25 01:15PM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Dec-04-25 08:00AM	Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research (Business Wire) +5.26%
Nov-18-25 09:40AM	Company News for Nov 18, 2025 (Zacks)
04:45AM	Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT (Insider Monkey)
Nov-17-25 10:13AM	Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity? (Insider Monkey)
Nov-14-25 02:01PM	Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -10.13%
08:25AM	Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:34AM	Twist Bioscience: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results (Business Wire)
Nov-13-25 09:15AM	MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -6.18%
Nov-12-25 08:10AM	Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:20PM	Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
09:11AM	Loading…
Nov-04-25 09:11AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More (24/7 Wall St.)
08:00AM	Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference (Business Wire)
Nov-03-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Oct-24-25 06:20AM	Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights (Business Wire) +7.16%
Oct-23-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025 (Business Wire)
Oct-22-25 08:53AM	Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3 (Insider Monkey) -6.98%
Oct-06-25 08:00AM	Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle Sequencing Workflow for the AVITI System (Business Wire)
Oct-02-25 02:00PM	Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design (Business Wire)
Sep-24-25 04:47AM	Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience (Zacks)
Sep-23-25 09:23AM	5 Biotech Stocks Worth Adding to Your Portfolio Now (Zacks)
Sep-18-25 11:35AM	3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025 (Zacks)
Sep-17-25 02:18PM	TD Cowen Reaffirms Buy on Twist Bioscience (TWST) Amid Scaling and Margin Gains (Insider Monkey)
Sep-03-25 08:00AM	Twist Bioscience to Present at Baird 2025 Global Healthcare Conference (Business Wire)
Sep-02-25 08:00AM	Twist Bioscience Collaborates with Synthetic Design Lab (Business Wire)
Aug-19-25 08:00AM	Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution (Business Wire)
Aug-13-25 07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-07-25 09:35AM	After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) (Zacks)
Aug-06-25 08:00AM	Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors (Business Wire) -5.89%
Aug-05-25 03:08AM	Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.90%
Aug-04-25 08:25AM	Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -10.30%
07:24AM	Twist Bioscience: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results (Business Wire)
Jul-31-25 08:00AM	Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model (Business Wire)
Jul-28-25 08:24AM	Is Twist Bioscience Corp. (TWST) Nearing Profitability? (Insider Monkey)
Jul-24-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jul-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 (Business Wire)
Jul-07-25 08:00AM	Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format (Business Wire) -6.76%
Jun-23-25 01:40AM	Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions (Insider Monkey)
May-22-25 08:00AM	Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions (Business Wire)
May-15-25 08:00AM	Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference (Business Wire)
May-13-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-08-25 11:43PM	Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) -5.49%
08:00AM	Twist Bioscience and Ginkgo Bioworks Revise Collaboration (Business Wire)
May-06-25 03:02AM	Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) -8.85%
01:18AM	Q2 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
May-05-25 11:41AM	Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript (Seeking Alpha) -8.44%
08:25AM	Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results (Business Wire)
07:10AM	Twist Bioscience Spins Out DNA Data Storage as Independent Company (Business Wire)
May-02-25 09:23AM	What To Expect From Twist Bioscience Corp (TWST) Q2 2025 Earnings (GuruFocus.com)
May-01-25 02:06PM	Twist Bioscience: Experiencing Solid Growth But Significantly Overvalued (Seeking Alpha)
12:05PM	Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers (Seeking Alpha)
Apr-24-25 08:00AM	Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System (Business Wire) +6.78%
Apr-14-25 08:00AM	Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025 (Business Wire)
Mar-31-25 09:03AM	The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics (Zacks)
08:00AM	Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics (Business Wire)
Mar-28-25 09:39AM	Promising Genomics & Synthetic Biology Stocks to Consider in 2025 (Zacks)
Mar-20-25 04:58PM	Twist Bioscience (TWST): The Worst High-Risk High-Reward Growth Stock to Buy (InsiderMonkey)
Mar-12-25 12:12PM	Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last? (Zacks)
Mar-11-25 07:30AM	Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost (Business Wire) +6.59%
Mar-01-25 02:38PM	Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? (Insider Monkey)
Feb-25-25 08:00AM	Twist Bioscience to Present at Upcoming Investor Conferences (Business Wire)
Feb-19-25 08:00AM	Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Feb-06-25 04:58PM	Twist Bioscience Corporation (TWST): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
12:00PM	Twist Bioscience (TWST) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-04-25 02:01AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:47AM	Q1 2025 Twist Bioscience Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-03-25 08:25AM	Twist Bioscience (TWST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:25AM	Twist Bioscience: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:15AM	Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results (Business Wire)
Jan-31-25 07:05AM	Twist Bioscience Corp (TWST) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
Jan-22-25 08:00AM	Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025 (Business Wire)
Dec-27-24 12:00PM	All You Need to Know About Twist Bioscience (TWST) Rating Upgrade to Buy (Zacks)
Dec-23-24 08:48AM	Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains? (Zacks)
Dec-19-24 08:00AM	Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-16-24 09:55AM	Twist Bioscience (TWST) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Dec-11-24 11:59AM	Why Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey) -5.24%
Nov-27-24 07:30AM	Twist Bioscience named a Best Idea for 2025 at TD Cowen (TipRanks)
Nov-20-24 09:15AM	AI's Growing Role in Transforming Healthcare Delivers Innovations in Diagnostics, Patient Care (PR Newswire)

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Finn Patrick John	Officer	Feb 12 '26	Proposed Sale	50.23	3,500	175,789		Feb 12 05:00 PM
Laponis Adam	Officer	Feb 12 '26	Proposed Sale	50.00	7,000	350,000		Feb 12 01:07 PM
Cho Dennis	Officer	Feb 11 '26	Proposed Sale	49.93	5,000	249,650		Feb 11 12:03 PM
JOHANNESSEN JAN	Director	Feb 06 '26	Sale	47.91	2,200	105,395	17,754	Feb 09 04:26 PM
JOHANNESSEN JAN	Director	Feb 06 '26	Proposed Sale	47.91	2,200	105,395		Feb 06 03:16 PM
Finn Patrick John	President and COO	Feb 03 '26	Sale	46.58	2,705	125,988	307,788	Feb 05 04:05 PM
Cho Dennis	See Remarks	Feb 03 '26	Sale	46.58	1,099	51,187	143,581	Feb 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Feb 03 '26	Sale	46.58	5,001	232,927	869,312	Feb 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 04 '26	Sale	45.65	7,000	319,536	58,738	Feb 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Feb 03 '26	Sale	46.58	175	8,151	65,738	Feb 05 04:05 PM
Green Paula	SVP of Human Resources	Feb 03 '26	Sale	46.58	1,194	55,612	165,445	Feb 05 04:05 PM
WERNER ROBERT F.	Officer	Feb 04 '26	Proposed Sale	45.65	7,000	319,533		Feb 04 02:29 PM
Finn Patrick John	Officer	Feb 03 '26	Proposed Sale	46.58	2,705	125,987		Feb 03 03:44 PM
WERNER ROBERT F.	Officer	Feb 03 '26	Proposed Sale	46.58	175	8,151		Feb 03 03:26 PM
Green Paula	Officer	Feb 03 '26	Proposed Sale	46.58	1,194	55,611		Feb 03 03:23 PM
Cho Dennis	Officer	Feb 03 '26	Proposed Sale	46.58	1,099	51,186		Feb 03 03:20 PM
Leproust Emily M.	Officer	Feb 03 '26	Proposed Sale	46.58	5,001	232,924		Feb 03 03:19 PM
Finn Patrick John	President and COO	Jan 23 '26	Sale	44.91	2,390	107,330	310,493	Jan 27 04:05 PM
Finn Patrick John	Officer	Jan 23 '26	Proposed Sale	44.91	2,390	107,329		Jan 23 03:17 PM
Laponis Adam	Chief Financial Officer	Jan 13 '26	Sale	40.00	3,000	120,000	137,031	Jan 15 04:13 PM
Finn Patrick John	President and COO	Jan 13 '26	Option Exercise	8.82	3,279	28,921	336,162	Jan 15 04:13 PM
Finn Patrick John	President and COO	Jan 13 '26	Sale	40.00	23,279	931,160	312,883	Jan 15 04:13 PM
Laponis Adam	Chief Financial Officer	Jan 09 '26	Sale	35.26	2,738	96,545	140,031	Jan 13 04:05 PM
Finn Patrick John	Officer	Jan 13 '26	Proposed Sale	40.00	23,279	931,160		Jan 13 02:46 PM
Laponis Adam	Officer	Jan 13 '26	Proposed Sale	40.00	3,000	120,000		Jan 13 02:42 PM
Laponis Adam	Officer	Jan 09 '26	Proposed Sale	35.26	2,738	96,544		Jan 09 03:12 PM
Green Paula	SVP of Human Resources	Dec 22 '25	Sale	34.56	273	9,434	166,639	Dec 23 04:05 PM
Cho Dennis	See Remarks	Dec 22 '25	Sale	34.56	324	11,196	144,680	Dec 23 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 22 '25	Sale	34.56	1,605	55,462	874,313	Dec 23 04:05 PM
Cho Dennis	Officer	Dec 22 '25	Proposed Sale	34.56	324	11,196		Dec 22 03:22 PM
Green Paula	Officer	Dec 22 '25	Proposed Sale	34.56	273	9,434		Dec 22 03:16 PM
Leproust Emily M.	Officer	Dec 22 '25	Proposed Sale	34.56	1,605	55,462		Dec 22 03:11 PM
Cho Dennis	See Remarks	Dec 08 '25	Sale	32.88	398	13,085	145,004	Dec 10 04:05 PM
Leproust Emily M.	Chief Executive Officer	Dec 08 '25	Sale	32.88	2,255	74,140	875,918	Dec 10 04:05 PM
Green Paula	SVP of Human Resources	Dec 08 '25	Sale	32.88	877	28,834	166,912	Dec 10 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Dec 08 '25	Sale	32.88	230	7,562	65,913	Dec 10 04:05 PM
Leproust Emily M.	Officer	Dec 08 '25	Proposed Sale	32.88	2,255	74,139		Dec 08 03:33 PM
Cho Dennis	Officer	Dec 08 '25	Proposed Sale	32.88	398	13,085		Dec 08 03:31 PM
Green Paula	Officer	Dec 08 '25	Proposed Sale	32.88	877	28,834		Dec 08 03:22 PM
WERNER ROBERT F.	Officer	Dec 08 '25	Proposed Sale	32.88	230	7,562		Dec 08 03:20 PM
Cho Dennis	See Remarks	Nov 21 '25	Sale	26.50	757	20,063	145,402	Nov 25 04:05 PM
Finn Patrick John	President and COO	Nov 21 '25	Sale	26.50	1,776	47,070	332,883	Nov 25 04:05 PM
Green Paula	SVP of Human Resources	Nov 21 '25	Sale	26.50	598	15,849	167,789	Nov 25 04:05 PM
Laponis Adam	Chief Financial Officer	Nov 21 '25	Sale	26.50	887	23,509	142,769	Nov 25 04:05 PM
Leproust Emily M.	Chief Executive Officer	Nov 21 '25	Sale	26.50	2,663	70,579	878,173	Nov 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 24 '25	Sale	28.71	822	23,599	66,143	Nov 25 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 21 '25	Sale	26.50	229	6,069	66,965	Nov 25 04:05 PM
WERNER ROBERT F.	Officer	Nov 24 '25	Proposed Sale	28.71	822	23,599		Nov 24 03:12 PM
WERNER ROBERT F.	Officer	Nov 21 '25	Proposed Sale	26.50	229	6,069		Nov 21 03:36 PM
Leproust Emily M.	Officer	Nov 21 '25	Proposed Sale	26.50	2,663	70,579		Nov 21 03:30 PM
Laponis Adam	Officer	Nov 21 '25	Proposed Sale	26.50	887	23,509		Nov 21 03:24 PM
Green Paula	Officer	Nov 21 '25	Proposed Sale	26.50	598	15,849		Nov 21 03:19 PM
Finn Patrick John	Officer	Nov 21 '25	Proposed Sale	26.50	1,776	47,070		Nov 21 03:18 PM
Cho Dennis	Officer	Nov 21 '25	Proposed Sale	26.50	757	20,063		Nov 21 03:14 PM
JOHANNESSEN JAN	Director	Nov 18 '25	Sale	24.77	7,044	174,480	14,859	Nov 20 04:05 PM
JOHANNESSEN JAN	Director	Nov 18 '25	Proposed Sale	24.77	7,044	174,480		Nov 18 11:54 AM
Cho Dennis	See Remarks	Nov 03 '25	Sale	32.08	1,019	32,689	120,694	Nov 05 04:05 PM
Finn Patrick John	President and COO	Nov 03 '25	Sale	32.08	2,755	88,379	265,919	Nov 05 04:05 PM
Green Paula	SVP of Human Resources	Nov 03 '25	Sale	32.08	1,084	34,774	142,187	Nov 05 04:05 PM
Leproust Emily M.	Chief Executive Officer	Nov 03 '25	Sale	32.08	4,887	156,772	733,922	Nov 05 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Nov 03 '25	Sale	32.08	160	5,133	50,870	Nov 05 04:05 PM
Cho Dennis	See Remarks	Oct 30 '25	Sale	31.44	6,515	204,860	121,713	Nov 03 04:05 PM
Finn Patrick John	President and COO	Oct 30 '25	Sale	31.44	17,606	553,608	268,674	Nov 03 04:05 PM
Green Paula	SVP of Human Resources	Oct 30 '25	Sale	31.44	6,920	217,595	143,271	Nov 03 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 30 '25	Sale	31.44	31,379	986,691	738,809	Nov 03 04:05 PM
Laponis Adam	Chief Financial Officer	Oct 30 '25	Sale	31.44	5,517	173,478	111,008	Nov 03 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Oct 30 '25	Sale	31.44	1,016	31,947	51,030	Nov 03 04:05 PM
WERNER ROBERT F.	Officer	Nov 03 '25	Proposed Sale	32.08	160	5,133		Nov 03 03:23 PM
Green Paula	Officer	Nov 03 '25	Proposed Sale	32.08	1,084	34,774		Nov 03 03:21 PM
Finn Patrick John	Officer	Nov 03 '25	Proposed Sale	32.08	2,755	88,379		Nov 03 03:19 PM
Leproust Emily M.	Officer	Nov 03 '25	Proposed Sale	32.08	4,887	156,772		Nov 03 03:18 PM
Cho Dennis	Officer	Nov 03 '25	Proposed Sale	32.08	1,019	32,689		Nov 03 03:12 PM
WERNER ROBERT F.	Officer	Oct 30 '25	Proposed Sale	31.44	1,016	31,947		Oct 30 04:00 PM
Cho Dennis	Officer	Oct 30 '25	Proposed Sale	31.44	6,515	204,860		Oct 30 03:52 PM
Leproust Emily M.	Officer	Oct 30 '25	Proposed Sale	31.44	31,379	986,691		Oct 30 03:50 PM
Finn Patrick John	Officer	Oct 30 '25	Proposed Sale	31.44	17,606	553,608		Oct 30 03:46 PM
Green Paula	Officer	Oct 30 '25	Proposed Sale	31.44	6,920	217,595		Oct 30 03:46 PM
Laponis Adam	Officer	Oct 30 '25	Proposed Sale	31.44	5,517	173,478		Oct 30 03:43 PM
Finn Patrick John	President and COO	Oct 23 '25	Sale	30.88	2,240	69,160	206,495	Oct 27 04:05 PM
Finn Patrick John	Officer	Oct 23 '25	Proposed Sale	30.87	2,240	69,160		Oct 23 03:13 PM
Laponis Adam	Chief Financial Officer	Oct 08 '25	Sale	31.15	3,000	93,450	94,042	Oct 10 04:05 PM
Laponis Adam	Chief Financial Officer	Oct 09 '25	Sale	32.92	2,517	82,865	91,525	Oct 10 04:05 PM
Laponis Adam	Officer	Oct 09 '25	Proposed Sale	32.92	2,517	82,864		Oct 09 03:13 PM
Laponis Adam	Chief Financial Officer	Oct 06 '25	Sale	32.19	5,875	189,099	97,042	Oct 08 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 06 '25	Sale	32.19	31,348	1,008,998	601,212	Oct 08 04:05 PM
WERNER ROBERT F.	Chief Accounting Officer	Oct 06 '25	Sale	32.19	2,041	65,694	46,413	Oct 08 04:05 PM
Green Paula	SVP of Human Resources	Oct 06 '25	Sale	32.19	9,724	312,986	114,678	Oct 08 04:05 PM
Finn Patrick John	President and COO	Oct 06 '25	Sale	32.19	23,747	764,345	208,735	Oct 08 04:05 PM
Cho Dennis	See Remarks	Oct 06 '25	Sale	32.19	3,876	124,757	98,710	Oct 08 04:05 PM
Laponis Adam	Officer	Oct 08 '25	Proposed Sale	31.15	3,000	93,450		Oct 08 09:50 AM
Laponis Adam	Officer	Oct 06 '25	Proposed Sale	32.19	5,875	189,099		Oct 06 05:18 PM
Leproust Emily M.	Officer	Oct 06 '25	Proposed Sale	32.19	31,348	1,008,998		Oct 06 05:15 PM
WERNER ROBERT F.	Officer	Oct 06 '25	Proposed Sale	32.19	2,041	65,694		Oct 06 05:09 PM
Finn Patrick John	Officer	Oct 06 '25	Proposed Sale	32.19	23,747	764,345		Oct 06 04:52 PM
Green Paula	Officer	Oct 06 '25	Proposed Sale	32.19	9,724	312,986		Oct 06 04:41 PM
Cho Dennis	Officer	Oct 06 '25	Proposed Sale	32.19	3,876	124,757		Oct 06 04:41 PM
Cho Dennis	See Remarks	Oct 02 '25	Sale	29.16	124	3,616	102,586	Oct 06 04:05 PM
Green Paula	SVP of Human Resources	Oct 02 '25	Sale	29.16	140	4,083	124,402	Oct 06 04:05 PM
Leproust Emily M.	Chief Executive Officer	Oct 02 '25	Sale	29.16	476	13,881	632,560	Oct 06 04:05 PM
Finn Patrick John	President and COO	Oct 02 '25	Sale	29.16	206	6,007	232,482	Oct 06 04:05 PM

Open in Screener

MASS

908 Devices Inc

Feb 13 • 01:06PM ET

6.62

+0.21 3.28 %

Healthcare • Medical Devices • USA • NASD

Peers: DHR A BRKR BIO WAT TECH MTD IART CAMT

| Held by: ARKG IWM VTI VXF IWO SCHA FITE VTWO IWC AVSC

Index	RUT	P/E	-	EPS (ttm)	-1.71	Insider Own	26.14%	Shs Outstand	36.12M	Perf Week	1.07%
Market Cap	239.60M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	-0.71%	Shs Float	26.73M	Perf Month	21.69%
Enterprise Value	131.90M	PEG	-	EPS next Q	-0.07	Inst Own	69.01%	Short Float	11.93%	Perf Quarter	12.20%
Income	-60.66M	P/S	4.16	EPS this Y	70.77%	Inst Trans	2.69%	Short Ratio	7.36	Perf Half Y	-6.36%
Sales	57.64M	P/B	1.75	EPS next Y	48.25%	ROA	-30.94%	Short Interest	3.19M	Perf YTD	26.10%
Book/sh	3.77	P/C	2.14	EPS next 5Y	48.47%	ROE	-42.72%	52W High	9.34 -29.12%	Perf Year	158.59%
Cash/sh	3.10	P/FCF	-	EPS past 3/5Y	-38.77% -32.72%	ROIC	-43.27%	52W Low	1.92 244.79%	Perf 3Y	-36.10%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.21% 27.11%	Gross Margin	45.54%	Volatility	6.64% 6.30%	Perf 5Y	-90.95%
Dividend TTM	-	EV/Sales	2.29	EPS Y/Y TTM	3.61%	Oper. Margin	-44.08%	ATR (14)	0.39	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	4.49%	Profit Margin	-105.24%	RSI (14)	55.68	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.49	EPS Q/Q	51.12%	SMA20	1.65%	Beta	0.48	Target Price	10.00
Payout	-	Debt/Eq	0.03	Sales Q/Q	-16.50%	SMA50	9.40%	Rel Volume	0.24	Prev Close	6.41
Employees	246	LT Debt/Eq	0.03	Earnings	Nov 10 BMO	SMA200	1.01%	Avg Volume	433.48K	Price	6.62
IPO	Dec 18, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	71.86% 3.18%	Trades		Volume	60,261	Change	3.28%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-25	Upgrade	Leerink Partners	Market Perform → Outperform	$12
Nov-13-24	Downgrade	Leerink Partners	Outperform → Market Perform	$12 → $4
Feb-07-23	Initiated	Stephens	Overweight	$14
Oct-15-21	Resumed	Cowen	Outperform
Jan-12-21	Initiated	William Blair	Outperform
Jan-12-21	Initiated	SVB Leerink	Outperform	$70
Jan-12-21	Initiated	Stifel	Buy	$65
Jan-12-21	Initiated	Cowen	Outperform

Feb-05-26 07:00AM	908 Devices Enhances MX908 Usability and Adds New Drug Targets (Business Wire)
Jan-21-26 04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
05:41AM	908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last? (Zacks)
Jan-20-26 07:00AM	908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025 (Business Wire) +19.20%
Nov-10-25 04:01PM	908 Devices Inc (MASS) Q3 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com) -13.35% -7.82%
08:15AM	Loading…
08:15AM	908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook (Business Wire)
Nov-07-25 07:22AM	What To Expect From 908 Devices Inc (MASS) Q3 2025 Earnings (GuruFocus.com) -5.38%
Nov-06-25 06:55PM	Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-05-25 06:00PM	Penumbra (PEN) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-04-25 08:15AM	InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Nov-03-25 10:00AM	Will 908 Devices Inc. (MASS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-30-25 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Oct-28-25 07:00AM	United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification (Business Wire)
07:00AM	Loading…
Oct-22-25 07:00AM	908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025 (Business Wire) -5.36%
Oct-16-25 07:00AM	United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices (Business Wire)
Sep-22-25 08:57AM	908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains? (Zacks)
Aug-05-25 08:20AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook (Business Wire)
Aug-04-25 10:07AM	Earnings To Watch: 908 Devices Inc (MASS) Reports Q2 2025 Result (GuruFocus.com)
07:00AM	908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors (Business Wire)
Jul-29-25 07:00AM	908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference (Business Wire) -5.18%
Jul-22-25 07:00AM	908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025 (Business Wire)
Jul-09-25 10:45AM	Innovation ETF (ARKK) Hits New 52-Week High (Zacks)
Jul-08-25 07:00AM	908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances (Business Wire) +6.24%
Jun-26-25 12:00PM	908 Devices (MASS) Upgraded to Buy: Here's What You Should Know (Zacks)
Jun-25-25 08:03AM	Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500 (Business Wire)
Jun-16-25 08:00AM	908 Devices Appoints Christopher D. Brown to its Board of Directors (Business Wire)
Jun-03-25 07:00AM	Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit (Business Wire) +11.26%
06:04PM	Loading…
May-30-25 06:04PM	Why 908 Devices Stock Rocketed More Than 18% Higher This Week (Motley Fool)
May-28-25 07:00AM	Romanian Customs Authority Adopts 908 Devices MX908 for Border Security Operations (Business Wire) +9.56%
May-26-25 12:00PM	All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy (Zacks)
May-22-25 07:00AM	908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference (Business Wire)
May-14-25 05:38AM	Q1 2025 908 Devices Inc Earnings Call (Thomson Reuters StreetEvents) -7.10%
03:08AM	908 Devices Inc (MASS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Losses (GuruFocus.com)
May-13-25 08:30AM	Bet On 4 Low-Beta Stocks BWB, LRN, MASS & PM Despite Tariff Truce (Zacks) -18.85%
08:15AM	908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	908 Devices Reports First Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook (Business Wire)
May-12-25 09:41AM	What To Expect From 908 Devices Inc (MASS) Q1 2025 Earnings (GuruFocus.com)
May-08-25 11:28PM	908 Devices Inc. (MASS): Among Nicholas J. Pritzker's Stock Picks with Huge Upside Potential (Insider Monkey) +6.63%
May-07-25 05:55PM	Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
10:00AM	Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know (Zacks)
May-06-25 10:00AM	908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:25AM	Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates (Zacks)
May-05-25 10:33AM	MTD Q1 Earnings Top Estimates, Sales Decline Y/Y, Shares Rise (Zacks)
Apr-30-25 07:00AM	908 Devices Equips rescEU Disaster Preparedness Reserve with Advanced Chemical Detection (Business Wire)
05:48AM	Why 908 Devices Inc. (MASS) is Surging in 2025 (Insider Monkey)
Apr-29-25 11:50PM	Q1 2025 Repligen Corp Earnings Call (Thomson Reuters StreetEvents)
Apr-23-25 08:29AM	Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue (Zacks)
Apr-22-25 07:00AM	908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation (Business Wire) +17.92%
Apr-16-25 11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks)
Apr-15-25 07:00AM	908 Devices Announces Preliminary First Quarter 2025 Financial Results (Business Wire)
Apr-08-25 05:58AM	The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP (Zacks)
Apr-07-25 08:00AM	5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market (Zacks)
Apr-01-25 06:55AM	New Strong Buy Stocks for April 1st (Zacks) -9.15%
Mar-11-25 07:00AM	908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device (Business Wire) +14.57%
Mar-05-25 05:14AM	Q4 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents) -13.14%
02:05AM	908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... (GuruFocus.com)
Mar-04-25 01:26PM	908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth (Benzinga) +95.96%
09:30AM	908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:45AM	908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
07:30AM	Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices (Business Wire)
Mar-03-25 05:00PM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire) -11.61%
04:30PM	908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 (Business Wire)
Jan-14-25 04:01PM	908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +46.97%
Dec-19-24 07:00AM	Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters (Business Wire)
Nov-13-24 02:10AM	908 Devices Inc (MASS) Q3 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges (GuruFocus.com) -19.86%
Nov-12-24 08:15AM	908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -19.34%
07:00AM	908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook (Business Wire)
Nov-11-24 07:21AM	What To Expect From 908 Devices Inc (MASS) Q3 2024 Earnings (GuruFocus.com)
Nov-04-24 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
Oct-22-24 07:00AM	908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 (Business Wire)
Oct-09-24 05:02PM	908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges (GuruFocus.com)
Sep-06-24 07:00AM	908 Devices to Participate in Craig-Hallum Bioprocessing Conference (Business Wire)
Aug-06-24 08:20AM	908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:00AM	908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook (Business Wire)
Jul-30-24 10:01AM	Earnings Preview: 908 Devices Inc. (MASS) Q2 Earnings Expected to Decline (Zacks)
07:00AM	908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-23-24 07:00AM	908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024 (Business Wire)
Jun-25-24 07:00AM	908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors (Business Wire)
Jun-18-24 07:00AM	908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors (Business Wire)
Jun-07-24 03:24AM	Should You Hold 908 Devices (MASS)? (Insider Monkey)
May-15-24 07:00AM	908 Devices to Participate in Upcoming Investor Conferences (Business Wire)
May-14-24 09:55AM	Wall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should Know (Zacks) +8.99%
May-09-24 09:35AM	908 Devices (MASS) Loses -9.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
May-01-24 08:49AM	908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:09AM	908 Devices Inc (MASS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Acquisitions ... (GuruFocus.com)
12:08AM	Q1 2024 908 Devices Inc. Earnings Call (Thomson Reuters StreetEvents)
Apr-30-24 11:53AM	MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
09:35AM	908 Devices Inc (MASS) Q1 2024 Earnings: Narrower Losses and Revenue Growth (GuruFocus.com)
08:55AM	908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:45AM	908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook (Business Wire)
07:30AM	908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering (Business Wire)
Apr-23-24 07:00AM	908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024 (Business Wire)
Mar-12-24 07:00AM	908 Devices Trace Chemical Identification Technology Adopted by European Agencies (Business Wire) +5.41%
Mar-07-24 12:02PM	908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-05-24 07:33AM	908 Devices Inc (MASS) Reports Growth Amidst Industry Headwinds (GuruFocus.com)
07:00AM	908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook (Business Wire)
Feb-29-24 07:00AM	908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares Fully Integrated Cell Therapy Manufacturing Platform (Business Wire)

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. It offers products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knopp Kevin J.	President and CEO	Feb 02 '26	Sale	6.18	34,764	214,842	795,968	Feb 03 08:45 PM
Griffith Joseph H. IV	Chief Financial Officer	Feb 02 '26	Sale	6.18	23,175	143,222	139,896	Feb 03 08:45 PM
Griffith Joseph H. IV	Chief Financial Officer	Oct 03 '25	Sale	9.05	4,292	38,849	92,930	Oct 06 12:41 PM
Griffith Joseph H. IV	Chief Financial Officer	Oct 02 '25	Sale	9.04	708	6,398	97,222	Oct 06 12:41 PM
JOSEPH H GRIFFITH IV	Officer	Oct 02 '25	Proposed Sale	8.99	5,000	44,950		Oct 02 04:24 PM
Griffith Joseph H. IV	Chief Financial Officer	Sep 19 '25	Sale	7.07	5,000	35,338	97,930	Sep 23 12:33 PM
JOSEPH H GRIFFITH IV	Officer	Sep 19 '25	Proposed Sale	6.82	5,000	34,100		Sep 19 04:26 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 16 '25	Sale	7.51	16,082	120,839	8,521	Jun 18 04:35 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 17 '25	Sale	7.51	7,148	53,653	1,373	Jun 18 04:35 PM
Turner Michael S.	Chief Legal & Admin Officer	Jun 18 '25	Sale	7.50	1,373	10,298	0	Jun 18 04:35 PM
MICHAEL S TURNER	Officer	Jun 16 '25	Proposed Sale	7.31	24,603	179,848		Jun 16 04:24 PM
Griffith Joseph H. IV	Chief Financial Officer	Jun 04 '25	Sale	7.08	6,940	49,135	102,930	Jun 06 05:51 PM
JOSEPH H GRIFFITH IV	Officer	Jun 04 '25	Proposed Sale	6.62	6,940	45,943		Jun 04 04:26 PM
Knopp Kevin J.	President and CEO	May 15 '25	Buy	4.44	15,000	66,596	722,733	May 19 04:37 PM
Spoto Mark	Director	May 14 '25	Buy	4.29	10,000	42,850	62,971	May 15 04:52 PM
Knopp Kevin J.	President and CEO	May 14 '25	Buy	4.32	15,000	64,788	707,733	May 14 04:28 PM

RGEN

Repligen Corp

TWST

Twist Bioscience Corp

MASS

908 Devices Inc

Upgrade your FINVIZ experience